Navigation Links
BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
Date:5/8/2009

BIRMINGHAM, Ala., May 8 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that, based on discussions with the U.S. Department of Health and Human Services/Biomedical Advanced Research and Development Authority (HHS-BARDA), it is preparing a portion of its inventory of finished peramivir for addition to the U.S. Centers for Disease Control and Prevention (CDC) Strategic National Stockpile. This inventory is sufficient for the treatment of approximately one thousand patients and will be delivered in the event that the government so instructs. Intravenous (i.v.) peramivir is currently undergoing a pre-emergency use authorization (EUA) review. Government agencies are considering the future option of providing peramivir through an EUA in the event of a severe influenza outbreak with significant hospitalizations. BioCryst is advancing the clinical development of peramivir under terms of a $102.6 million, four-year contract from the HHS.

"BioCryst is working diligently with government agencies to provide i.v. peramivir as a treatment option for an influenza emergency," said Jon P. Stonehouse, President and Chief Executive Officer of BioCryst. "With its parenteral route of administration, peramivir has the potential to help patients who may have difficulty with an oral or inhaled anti-viral medication. In addition, BioCryst is in negotiations with the Division of Microbiology and Infectious Diseases (DMID) and the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) to conduct a study of peramivir in a pediatric patient population."

The clinical activity of peramivir has previously been demonstrated in various clinical studies. The sensitivity of the swine flu virus to peramivir has recently been reported by the CDC (1). Ten of the thirteen isol
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
2. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
3. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
4. BioCryst Updates Peramivir Clinical Development Plan
5. BioCryst Provides Forodesine HCl Update
6. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
7. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
8. USAID Provides $5M in Emergency Support as Swine Flu Spreads
9. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
10. Strativa Pharmaceuticals Provides Product Pipeline Update
11. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Imaging (TDI), part of a Health & Wellness ... superior quality infrared imaging of the breast, neuromuscular ... assist in the early diagnosis of problems associated ... imaging cameras that "read" the entire infrared range ...
(Date:12/4/2009)... Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that ... Phase II-b, dose escalation, clinical trial in Switzerland for ... Oxycyte is the Company,s perfluorocarbon (PFC) therapeutic oxygen carrier. ... the outcome of patients with severe TBI. We hope ...
(Date:12/4/2009)... 4 Hospira, Inc. (NYSE: HSP ), ... today announced the launch of its next-generation 50 mL ... and solutions, and now offers a complete size range ... responsible VisIV product. The launch of the 50 mL ...
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 1LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 2LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 4RealMed Named Exclusive Medical Claims Clearinghouse for Physicians by Adventist Health System 53483 1RealMed Named Exclusive Medical Claims Clearinghouse for Physicians by Adventist Health System 53483 2RealMed Named Exclusive Medical Claims Clearinghouse for Physicians by Adventist Health System 53483 3Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 1Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 3Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 4
... Sept. 12 Alfacell Corporation,(Nasdaq: ACEL ) ... events,(patient deaths) have occurred in the Phase IIIb ... treatment of patients with unresectable,malignant mesothelioma. The number ... that total events in the study had reached ...
... Staphylococcus Aureus and Methicillin-Resistant Staphylococcus Aureus ... BD Diagnostics, a segment,of BD (Becton, Dickinson and Company) ... a 510(k) submission to the U.S. Food and Drug ... assay. This will,be the first assay for rapid and ...
Other Medicine Technology:Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 2Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 3BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery 2BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery 3
(Date:12/5/2009)... of International Solutions, an innovative new international private medical insurance plan ... addition to offering customers the flexibility to add or remove a ... Solutions enables customers to tailor their benefits to complement those already ... ...
(Date:12/5/2009)... popping up in the most unusual places, and to do everything from ... ... December 5, 2009 -- Who would have thought that your wine, water ... Worth, Texas has announced a new line of turbines, for industry end ...
(Date:12/4/2009)... Investment Trust Inc. (NYSE: CRE ) ("Care" or ... a dividend of $0.17 per share of common stock. The ... record on December 14, 2009. ,, About ... real estate investment and finance company investing in healthcare-related real estate ...
(Date:12/4/2009)... has won the Patient,s Choice Award as the favorite ... conducted by the online website, www.weedmaps.com. Despite ... has selected Medithrive as the preeminent location for accessing ... popularity of Medithrive confirms the obvious: a dispensary which ...
(Date:12/4/2009)... WASHINGTON, Dec. 4 The American Association of Homes and ... that the Community Living and Supportive Services (CLASS) provisions ... provisions are essential for providing support to elders, people with ... to pass a health care reform bill that will make ...
Breaking Medicine News(10 mins):Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
... one of two classes of available drugs is a cost-effective ... are likely a better bet. // ,Researchers compared the ... adults with the flu or a flu-like illness. The strategies ... treatment with an anti-flu drug, and treating patients without testing., ...
... High blood pressure is becoming more common around the world. ... ,Many guidelines currently call for anywhere between half an ... of the week to reduce the risk of heart disease, ... women who had high blood pressure but were otherwise healthy. ...
... that sage can significantly improve memory.,New research shows a ... Alzheimer's disease. // ,A team of researchers tested ... Some were given sage oil capsules, and some were ... took the sage oil performed significantly better than those ...
... a new way to treat certain kinds of cancer ... far more high-energy radioactivity than current radio-isotopes used to ... invade bone marrow. For many years, doctors have used ... metastases. ,The radio-isotopes ease pain by accumulating in ...
... A non-surgical dental procedure -- known as scaling and root ... pregnant women with periodontal disease, //according to a new study. ... of dentistry studied more than 350 pregnant women who had ... supporting bone that hold teeth in the mouth. Study participants ...
... It appears one of the most devastating diseases to hit ... from the Rush Institute //on Healthy Aging say it is ... use of public health planning. Current estimates vary depending on ... the United States Census as the scaffold to build upon., ...
Other Medicine News:
The Tissue Cassette Storage Cabinet is made of strong, laminated fiberboard....
Cardboard Block Filing Cabinet is an economical solution for block storage needs....
Scienceware® Slide Tray Cabinet holds twelve Scienceware® H44581 microscope trays horizontally in a dust free enclosure....
Compact storage cabinets for 35 mm slides....
Medicine Products: